SEK0.625 0.0 0.0%
Last Trade - 08/09/20
| Market Cap | £4.91m |
| Enterprise Value | £4.11m |
| Revenue | £72.2k |
| Position in Universe | th / 1874 |
| Industry | Market | |
|---|---|---|
|
|
|
|
|
|
|
|
|
|
|
| Year End 31st Dec | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020E | 2021E | CAGR / Avg | |
|---|---|---|---|---|---|---|---|---|---|---|
| 0.000 | 0.65 | 0.17 | 1.00 | 0.95 | 1.16 | |||||
|
x
|
||||||||||
| Profitability | ||||||||||
|
%
|
||||||||||
|
%
|
||||||||||
|
%
|
||||||||||
| Cashflow | ||||||||||
| Dividends | ||||||||||
| Balance Sheet | ||||||||||
|
m
|
||||||||||
|
m
|
||||||||||
|
m
|
||||||||||
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing % | |||
| Net Gearing % | |||
| Cash / Assets % |
| Liquidity (ttm) | ||
|---|---|---|
| Curr. Ratio | ||
| Quick Ratio | ||
| Interest Cov. | ||
| Efficiency (ttm) | ||
|---|---|---|
| Asset Turnover | ||
| Recs Turnover | ||
| Stock Turnover | ||
| Latest interim period vs. prior period | Industry | Market |
|---|---|---|
|
|
|
|
|
|
|
| 3yr Compound Annual Growth Rate | Industry | Market |
|---|---|---|
|
|
|
|
|
|
|
|
|
|
|
Revenue
Net Income
Normalised EPS
PE Ratio Range
Dividend Yield Range
|
Price Target:
( below Price)
|
31st Dec 2021
|
31st Dec 2022
|
||||
|---|---|---|---|---|---|---|
| Est. Long Term Growth Rate: |
Net Profit () |
EPS () |
DPS () |
Net Profit () |
EPS () |
DPS () |
| Consensus Estimate | ||||||
| 1m Change | ||||||
| 3m Change | ||||||
Chordate Medical Holding AB (publ) is a medical technology company based in Sweden. The Company develops treatment method through nerve stimulation for chronic nasal congestion. The Company’s headquartered is located in Kista, Sweden.
| Last Annual | December 31st, 2019 |
| Last Interim | September 30th, 2020 |
| No. of Shareholders: | n/a |
| No. of Employees: | n/a |
| Sector | Healthcare |
| Industry | Healthcare Equipment & Supplies |
| Index | |
| Exchange | Nordic Growth Market - Stockholm (Dual Listing) |
| Shares in Issue | 108,805,832 |
| Free Float | (0.0%) |
| Eligible for |
ISAs
SIPPs
|
| Address | Kistagangen 20 B, KISTA, 164 40, Sweden |
| Web | https://www.chordate.com/ |
| Phone | +46 8 40011586 |
| Contact | Anders Weilandt (Acting Chief Executive Officer, Director) |
| Auditors | PricewaterhouseCoopers AB |
As of 08/09/20, shares in Chordate Medical Holding publ AB are trading at SEK0.625, giving the company a market capitalisation of £4.91m. This share price information is delayed by 15 minutes.
Shares in Chordate Medical Holding publ AB are currently trading at SEK0.625 and the price has moved by % over the past 365 days. In terms of relative price strength - which takes into account the overall market trend - the Chordate Medical Holding publ AB price has moved by % over the past year.
There are no analysts currently covering Chordate Medical Holding publ AB.
Chordate Medical Holding publ AB is scheduled to issue upcoming financial results on the following dates:
Chordate Medical Holding publ AB does not currently pay a dividend.
Chordate Medical Holding publ AB does not currently pay a dividend.
Chordate Medical Holding publ AB does not currently pay a dividend.
To buy shares in Chordate Medical Holding publ AB you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
Shares in Chordate Medical Holding publ AB are currently trading at SEK0.625, giving the company a market capitalisation of £4.91m.
Here are the trading details for Chordate Medical Holding publ AB:
We were not able to load our ranking data for Chordate Medical Holding publ AB
We were not able to load any forecast data for Chordate Medical Holding publ AB.
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Chordate Medical Holding publ AB. Over the past six months, the relative strength of its shares against the market has been %. At the current price of SEK0.625, shares in Chordate Medical Holding publ AB are trading at % against their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
We were not able to find PE ratio data for Chordate Medical Holding publ AB.
Chordate Medical Holding publ AB's management team is headed by:
Here are the top five shareholders of Chordate Medical Holding publ AB based on the size of their shareholding:
